RHYTHM Biosciences Ltd Cash Flow-to-Debt Ratio
RHYTHM Biosciences Ltd cash flow-to-debt ratio. RHYTHM Biosciences Ltd (RHY) has a Cash Flow-to-Debt Ratio of -2.33x as of December 2025, meaning its operating cash flow of AU$-2.22 Million could theoretically repay -2% of its total liabilities (AU$955.41K) in one year. Check RHY cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of RHYTHM Biosciences Ltd (2017–2025)
Cash flow-to-debt ratio of RHYTHM Biosciences Ltd from 2017 to 2025. Historical debt coverage capacity for RHYTHM Biosciences Ltd across 9 annual periods. Check cash flow reinvestment rate of RHYTHM Biosciences Ltd to assess the company's total reinvestment commitment from operating cash flow.
RHYTHM Biosciences Ltd Cash Flow-to-Debt Ratio by Year (2017–2025)
RHYTHM Biosciences Ltd cash flow-to-debt ratio by year from 2017 to 2025. Year-by-year debt coverage analysis for RHYTHM Biosciences Ltd. For the full cash flow conversion analysis, see how efficiently does RHYTHM Biosciences Ltd generate cash.
| Year | CF-to-Debt Ratio | Operating CF (AUD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.35x | AU$-2.92 Million | AU$2.17 Million | ▲ +85.7% |
| 2024 | -9.42x | AU$-6.14 Million | AU$651.54K | ▼ -146.5% |
| 2023 | -3.82x | AU$-6.96 Million | AU$1.82 Million | ▲ +34.5% |
| 2022 | -5.83x | AU$-6.21 Million | AU$1.07 Million | ▼ -47.1% |
| 2021 | -3.96x | AU$-5.40 Million | AU$1.36 Million | ▼ -16.0% |
| 2020 | -3.42x | AU$-2.74 Million | AU$802.85K | ▲ +55.9% |
| 2019 | -7.75x | AU$-2.94 Million | AU$379.71K | ▲ +30.9% |
| 2018 | -11.20x | AU$-1.65 Million | AU$147.38K | ▼ -10901215.7% |
| 2017 | 0.00x | AU$-13.00 | AU$126.48K | — |